Novopharm Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.47 M
- Company Age 23 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth 13.66%
- Profit Growth 32.38%
- Ebitda 27.19%
- Net Worth 27.73%
- Total Assets 32.68%
About Novopharm Life Sciences
Novopharm Life Sciences Private Limited (NLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 February 2002 and has a history of 23 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.47 M.
The company currently has active open charges totaling ₹2.00 Cr.
Lakhvinder Arora, Harpreet Arora, and Rajeev Anand serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231DL2002PTC114142
-
Company No.
114142
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Feb 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Novopharm Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harpreet Arora
|
Director | 07-Feb-2002 | Current |
|
Lakhvinder Arora
|
Director | 07-Feb-2002 | Current |
|
Rajeev Anand
|
Director | 01-May-2008 | Current |
Financial Performance of Novopharm Life Sciences.
Novopharm Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.66% increase. The company also saw a substantial improvement in profitability, with a 32.38% increase in profit. The company's net worth Soared by an impressive increase of 27.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novopharm Life Sciences?
In 2020, Novopharm Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
M H Medicus Private LimitedLakhvinder Arora and Harpreet Arora are mutual person
-
Novomax Pharma Private Limited
Lakhvinder Arora, Harpreet Arora and 1 more are mutual person
-
Mex Pharma Private Limited
Lakhvinder Arora is a mutual person
-
Panchdeep Medi-Care Private Limited.
Lakhvinder Arora and Harpreet Arora are mutual person
-
Danica Pharma Private Limited
Harpreet Arora is a mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Nov 2021 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Novopharm Life Sciences?
Unlock and access historical data on people associated with Novopharm Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novopharm Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novopharm Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.